12 FEBRUARY

NEW ZEALAND GAZETTE

Insulins
Laronidase-rch
Levetiracetam
Levosimendan
Lignocaine; for oral use except in throat lozenges containing 30 milligrams or less per dose form; for ophthalmic use except when used in practice by a registered optometrist; for injection except when used as a local anaesthetic in practice by a registered nurse or podiatrist or by a dental therapist; for external use in medicines containing more than 10%
Lumiracoxib
Melagatran
Memantine
Nicoumalone
Nitrofurazone
Nux vomica
Pneumococcal vaccine; except in oral vaccines for the prophylaxis of bacterial complications of colds
Podophyllum emodi; for internal use; for external use for the treatment of anogenital warts; for other external use in medicines containing more than 20% of podophyllin
Podophyllum peltatum; for internal use; for external use for the treatment of anogenital warts; for other external use in medicines containing more than 20% of podophyllin
Podophyllotoxin; for internal use; for external use for the treatment of anogenital warts; for other external use in medicines containing more than 1%
Polyacrilamide; in injections or implantations for tissue augmentation or cosmetic use
Polylactic acid; in injections or implantations for tissue augmentation or cosmetic use
Poractant alfa
Pramocaine
Pregnenolone
Prilocaine; for injection except when used as a local anaesthetic by a dental therapist; except when specified elsewhere in the Schedule
Prochlorperazine; except when specified elsewhere in the Schedule; except when sold for the treatment of nausea associated with emergency contraception by pharmacists or nurses accredited to sell levonorgestrel for emergency contraception
Propantheline
Protamine sulphate
Quinisocaine
Sabadilla; except when specified elsewhere in the Schedule
Sodium picosulfate; in oral laxative preparations
Strychnos spp
Thiomesterone
Thiourea; except in medicines containing 0.1% or less
Vardenafil
Ximelagatran

Schedule 2
Restricted Medicines
Diclofenac; in solid dose form containing 25 milligrams or less and more than 12.5 milligrams per dose form in packs of not more than 30 tablets or capsules
Erythryl tetranitrate
Fluorides; in pastes, gels or powders for cleaning the teeth containing more than 0.1%
Glyceryl trinitrate; for oral or sublingual use
Haemophilus influenzae vaccine; in oral vaccines for the prophylaxis of bacterial complications of colds

315

Hyoscine butylbromide; for oral use in medicines containing not more than 10 milligrams per dose form and in packs containing not more than 20 tablets or capsules
Isosorbide dinitrate; for oral use in medicines containing 10 milligrams or less per dose form
Mannityl hexanitrate
Pneumococcal vaccine; in oral vaccines for the prophylaxis of bacterial complications of colds
Podophyllum emodi; for external use for the treatment of warts other than anogenital warts in medicines containing 20% or less and more than 10% of podophyllin
Podophyllum peltatum; for external use for the treatment of warts other than anogenital warts in medicines containing 20% or less and more than 10% of podophyllin
Podophyllotoxin; for external use for the treatment of warts other than anogenital warts in medicines containing 1% or less and more than 0.5%
Prochlorperazine; in packs containing not more than 10 tablets for the treatment of nausea associated with migraine or emergency contraception
Salicylic acid; in medicines containing more than 40%
Silver sulfadiazine; except for external use in packs containing 50 grams or less
Sodium picosulfate; in preparations for bowel cleansing prior to diagnostic, medical or surgical procedures

Schedule 3
Pharmacy-only Medicines
Aciclovir; for external use for the treatment of herpes labialis except in medicines containing 5% or less and in tubes containing 3 grams or less
Amethocaine; for external use in medicines containing 10% or less and more than 2%
Atropa belladonna; for external use in medicines containing 0.03% of the alkaloids of belladonna; for oral use in liquid form in medicines containing 0.03% or less and 0.3 milligrams or less per dose and not more than 1.2 milligrams per recommended daily dose of the alkaloids of belladonna or in solid dose form in medicines containing 0.3 milligrams or less per dose form and not more than 1.2 milligrams per recommended daily dose of the alkaloids of belladonna
Atropine; for oral use in liquid form in medicines containing 0.03% or less and 0.3 milligrams or less per dose and not more than 1.2 milligrams per recommended daily dose or in solid dose form in medicines containing 0.3 milligrams or less per dose form and not more than 1.2 milligrams per recommended daily dose; in medicines containing atropine sulfate for the treatment of organophosphorous poisoning either in packs of up to 20 tablets containing 0.6 milligrams or less per tablet or in injections in packs of 5 or less containing 0.6 milligrams per millilitre or less; except when used as an antidote in a device designed for self-injection; except when sold by licencees under the Toxic Substances Regulations
Benzocaine; for external use in medicines containing 10% or less and more than 2%
Benzydamine; for external use
Bifonazole; for external use except in medicines for tinea pedis only or in shampoos containing 1% or less
Cinchocaine; for external use in medicines containing 0.5% or less
Datura spp; for oral use in liquid form in medicines containing 0.03% or less and 0.3 milligrams or less per dose and not more than 1.2 milligrams per recommended daily dose of total solanaceous alkaloids or in solid dose form in medicines containing 0.3 milligrams or less